Target intelligence / Profile preview

Heat shock protein 90 (fungal) (Hsp90)

Target
Hsp90
Molecular classification
Enzyme, Molecular chaperone, ATPase
01

Overview

Heat shock protein 90 (Hsp90) is a highly conserved and essential molecular chaperone in fungi that plays a pivotal role in maintaining cellular proteostasis and orchestrating responses to environmental stress (4, 9). It functions as an ATPase-dependent chaperone that stabilizes a specific subset of 'client proteins,' including key signal transducers like calcineurin and protein kinase C (PKC), which are critical for fungal virulence, morphogenesis, and the development of drug resistance (2, 14). In major human pathogens such as Candida albicans and Aspergillus fumigatus, Hsp90 enables the emergence and maintenance of resistance to common antifungal classes like azoles and echinocandins by buffering the phenotypic effects of genetic variation (6, 13). Pharmacological inhibition of fungal Hsp90, often using repurposed anticancer agents like 17-AAG, can convert fungistatic drugs into fungicidal combinations and restore susceptibility in resistant strains (10, 11). However, the significant structural similarity between fungal and mammalian Hsp90 presents a major therapeutic challenge, as non-selective inhibition often leads to severe host toxicity and dose-limiting side effects (1, 19).

Other names
Hsp82Hsc8290 kDa heat shock proteinExtracellular Hsp90 (eHsp90)
02

Mechanism of action

Inhibition of the N-terminal ATPase activity of Hsp90, which prevents the chaperone cycle and leads to the destabilization and degradation of essential client proteins required for fungal survival and stress response.

03

Biological functions

Protein foldingStress responseSignal transductionMorphogenesisDrug resistanceVirulenceProteostasisEvolutionary capacitor
04

Disease associations

Infection
05

Safety considerations

Host toxicity due to high conservation between fungal and human Hsp90HepatotoxicityOcular toxicityImmunosuppressionDose-limiting toxicities (DLTs) in clinical trials
06

Interacting drugs

Geldanamycin

6 more in the full profile.

07

Biomarkers

Hsp90 expression levelsCalcineurin levelsMkc1 levelsHsp90 phosphorylation status (e.g., S530)Extracellular Hsp90 (eHsp90)

Beyond the preview

Go deeper on Heat shock protein 90 (fungal) (Hsp90).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein 90 (fungal) (Hsp90).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call